Although the detection of accumulated immunoreactive p53 protein in cancer cells by immunohistochemical staining is an established method suggesting the dysfunction of p53 protein [30], our present findings indicated that the observation of positive staining of immunoreactive p53 protein was clinically more effective than the detection of TP53 gene mutations. The gene discussed is TP53; the disease is cancer.